CORALreef Lipids Trial of Enlicitide an Oral PCSK-9 Inhibitor Demonstrates Substantial Efficacy
By Peter A. McCullough, MD, MPH Statins have been bedrock in lipid lowering therapy for decades but have come with adverse effects that are subject to exaggeration and discontinuation. Many have asked is there a new class of drugs that will someday replace statins? This post signifies a breakthrough. The CORALreef Lipids trial was a […]
Discuss on Nostr!
Nostr Note ID note1l2g558260x9nhg2rgsa95cu4cnktlc67u8ms8l42znmvlyjn3ltqspqtn0 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send cryptocurrency to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Send altcoins or fiat:
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.